• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

κ免疫球蛋白增强子结合蛋白Nf-κB通过翻译后机制的可诱导性。

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

作者信息

Sen R, Baltimore D

出版信息

Cell. 1986 Dec 26;47(6):921-8. doi: 10.1016/0092-8674(86)90807-x.

DOI:10.1016/0092-8674(86)90807-x
PMID:3096580
Abstract

NF-kappa B is a nuclear protein, found only in cells that transcribe immunoglobulin light chain genes, that interacts with a defined site in the kappa immunoglobulin enhancer. This protein can be induced in pre-B cells by stimulation with bacterial lipopolysaccharide (LPS). The induction involves a posttranslational activation, and the combined action of LPS and cycloheximide causes a superinduction. An active phorbol ester also induces this factor, and with kinetics more rapid than those for LPS stimulation. Phorbol-ester-mediated induction of NF-kappa B was observed in a T cell line (Jurkat) and a nonlymphoid cell line (HeLa), and is therefore not restricted to B-lymphoid cells. We interpret these results to indicate that factors that control transcription of specific genes in specific cells may be activated by posttranslational modification of precursor factors present more widely.

摘要

核因子-κB是一种核蛋白,仅在转录免疫球蛋白轻链基因的细胞中发现,它与κ免疫球蛋白增强子中的一个特定位点相互作用。这种蛋白可通过用细菌脂多糖(LPS)刺激在前B细胞中诱导产生。诱导涉及翻译后激活,LPS和环己酰亚胺的联合作用会导致超诱导。一种活性佛波酯也可诱导该因子,其动力学比LPS刺激的更快。在T细胞系(Jurkat)和非淋巴细胞系(HeLa)中观察到佛波酯介导的核因子-κB诱导,因此不限于B淋巴细胞。我们将这些结果解释为表明,控制特定细胞中特定基因转录的因子可能通过更广泛存在的前体因子的翻译后修饰而被激活。

相似文献

1
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.κ免疫球蛋白增强子结合蛋白Nf-κB通过翻译后机制的可诱导性。
Cell. 1986 Dec 26;47(6):921-8. doi: 10.1016/0092-8674(86)90807-x.
2
The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells.NF-κB结合位点介导非淋巴细胞中佛波酯诱导的转录。
Mol Cell Biol. 1988 Aug;8(8):3526-31. doi: 10.1128/mcb.8.8.3526-3531.1988.
3
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.NF-κB转录因子一个明显位于细胞质的前体中DNA结合活性的激活。
Cell. 1988 Apr 22;53(2):211-7. doi: 10.1016/0092-8674(88)90382-0.
4
Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.与核因子NF-κB结合的寡核苷酸充当淋巴细胞特异性且可诱导的增强子元件。
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1482-6. doi: 10.1073/pnas.85.5.1482.
5
Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.免疫球蛋白κ链和白细胞介素-2受体α链基因中功能不同的核因子κB结合位点。
Science. 1989 Apr 28;244(4903):466-9. doi: 10.1126/science.2497520.
6
Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core.前B细胞中免疫球蛋白κ轻链3'增强子的激活与一种核因子结合活性核心侧翼序列的抑制相关。
Nucleic Acids Res. 1994 May 11;22(9):1576-82. doi: 10.1093/nar/22.9.1576.
7
Lipopolysaccharide-unresponsive mutant pre-B-cell lines blocked in NF-kappa B activation.脂多糖无反应性突变前B细胞系在NF-κB激活中受阻。
Mol Cell Biol. 1990 Jan;10(1):422-5. doi: 10.1128/mcb.10.1.422-425.1990.
8
Induction of kappa transcription by interferon-gamma without activation of NF-kappa B.γ干扰素诱导κ转录而不激活核因子κB。
Science. 1988 Nov 18;242(4881):1036-7. doi: 10.1126/science.3143155.
9
I kappa B: a specific inhibitor of the NF-kappa B transcription factor.IκB:NF-κB转录因子的特异性抑制剂。
Science. 1988 Oct 28;242(4878):540-6. doi: 10.1126/science.3140380.
10
The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.κ增强子及其结合因子核因子κB在κ基因转录发育调控中的作用。
Cell. 1987 Jan 16;48(1):121-8. doi: 10.1016/0092-8674(87)90362-x.

引用本文的文献

1
NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy.骨肉瘤中的核因子κB信号通路:从信号网络到靶向治疗
Front Oncol. 2025 Jul 25;15:1565760. doi: 10.3389/fonc.2025.1565760. eCollection 2025.
2
Gut modulation to regulate NF-κB in colorectal and gastric cancer therapy and inflammation.肠道调节在结直肠癌和胃癌治疗及炎症中对核因子-κB的调控作用
Cancer Immunol Immunother. 2025 Jul 12;74(8):264. doi: 10.1007/s00262-025-04118-9.
3
Multi-species analysis of inflammatory response elements reveals ancient and lineage-specific contributions of transposable elements to NF-kB binding.
炎症反应元件的多物种分析揭示了转座元件对NF-κB结合的古老和谱系特异性贡献。
Genome Res. 2025 Jul 1;35(7):1544-1559. doi: 10.1101/gr.280357.124.
4
Stepwise neofunctionalization of the NF-κB family member Rel during vertebrate evolution.脊椎动物进化过程中NF-κB家族成员Rel的逐步新功能化。
Nat Immunol. 2025 May;26(5):760-774. doi: 10.1038/s41590-025-02138-2. Epub 2025 Apr 30.
5
An era of immunological discoveries heralded by molecular biology.一个由分子生物学引领的免疫学发现时代。
Trends Immunol. 2025 May;46(5):364-371. doi: 10.1016/j.it.2025.03.003. Epub 2025 Apr 15.
6
Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature.药用植物干预神经炎症的分子机制:当前文献的批判性叙述性综述
Pharmaceuticals (Basel). 2025 Jan 20;18(1):133. doi: 10.3390/ph18010133.
7
PTPN20 promotes metastasis through activating NF-κB signaling in triple-negative breast cancer.PTPN20 通过激活三阴性乳腺癌中的 NF-κB 信号通路促进转移。
Breast Cancer Res. 2024 Nov 6;26(1):155. doi: 10.1186/s13058-024-01910-w.
8
The role of NF-κB-SOX9 signalling pathway in osteoarthritis.NF-κB-SOX9信号通路在骨关节炎中的作用。
Heliyon. 2024 Aug 30;10(17):e37191. doi: 10.1016/j.heliyon.2024.e37191. eCollection 2024 Sep 15.
9
Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti.非偏斜性 X 染色体失活导致伴失禁型色素失禁症的 NF-κB 必需调节剂(NEMO)Δ-外显子 5-自炎症综合征(NEMO-NDAS)在女性中发生。
J Clin Immunol. 2024 Sep 12;45(1):1. doi: 10.1007/s10875-024-01799-2.
10
Licochalcone A: a review of its pharmacology activities and molecular mechanisms.甘草查尔酮A:其药理活性及分子机制综述
Front Pharmacol. 2024 Aug 12;15:1453426. doi: 10.3389/fphar.2024.1453426. eCollection 2024.